GSK's antibiotic drug gepotidacin gets priority review by FDA-March 2024-www.financetom.com

GSK's antibiotic drug gepotidacin gets priority review by FDA

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

GSK's antibiotic drug gepotidacin gets priority review by FDA

Aug 10, 2025 11:20 PM

Aug 11 (Reuters) - British drugmaker GSK said on

Monday its supplemental new drug application for antibiotic drug

gepotidacin has been accepted for priority review by the U.S.

Food and Drug Administration for the oral treatment of

uncomplicated urogenital gonorrhoea.

Previous page： Union Pacific expects revenue to grow faster than volumes over next three years Next page： Swiss regulator investigating Credit Suisse's final months, report says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Union Pacific expects revenue to grow faster than volumes over next three years

Sep 22, 2024

(Reuters) - U.S. railroad Union Pacific ( UNP ) said on Thursday it expects its revenue to grow faster than volumes over the next three years, outpacing the market. In the filing released ahead of the company's investor day event, Union Pacific ( UNP ) forecast an earnings per share compound annual growth rate (EPS CAGR) in the high single...

Swiss regulator investigating Credit Suisse's final months, report says

Sep 22, 2024

ZURICH (Reuters) - Swiss financial market regulator FINMA ordered an audit into Credit Suisse's handling of events leading to its demise in 2023, when the bank was acquired by its longtime rival UBS, Swiss newspaper SonntagsZeitung reported on Sunday. According to the paper, FINMA is looking at the 15 months prior to the state-orchestrated merger in March last year, for...

Tesla's Robotaxi Event Draws Tech Investor Interest, Auto Industry Skepticism, UBS Says

Sep 22, 2024

11:58 AM EDT, 09/19/2024 (MT Newswires) -- Tesla's (TSLA) robotaxi event on Oct. 10 is attracting interest from tech investors and skepticism from the auto industry, UBS Securities said in a note on Thursday. Since the event will have a lot of 'tech' eyes on it, there is an opportunity for Tesla to not only convince that investor base that...

FibroBiologics Enlists Southern Star for Contract Research Organization Services in Australia

Sep 22, 2024

12:43 PM EDT, 09/19/2024 (MT Newswires) -- FibroBiologics ( FBLG ) said Thursday it engaged Southern Star Research to provide contract research organization services to the company in Australia. Initial services cover preparatory work for a phase 1/2 study that will evaluate product candidate CYWC628 for the treatment of diabetic foot ulcers, FibroBiologics ( FBLG ) said. Shares of the...